APO Research
Talk to an analyst

APO RESEARCH · REPORT

Taditional Chinese Medicine (TCM) for COVID-19

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Taditional Chinese Medicine (TCM) for COVID-19 Industry Growth and Trends Forecast to 2032

31 December 2025101 pages

Choose your research edition.

Industry ResearchTaditional Chinese Medicine (TCM) for COVID-19 Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Taditional Chinese Medicine (TCM) for COVID-19 Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Taditional Chinese Medicine (TCM) for COVID-19 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Taditional Chinese Medicine (TCM) for COVID-19 Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Taditional Chinese Medicine (TCM) for COVID-19 Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

According to APO Research, the global Taditional Chinese Medicine (TCM) for COVID-19 market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Taditional Chinese Medicine (TCM) for COVID-19 is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Taditional Chinese Medicine (TCM) for COVID-19 is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Taditional Chinese Medicine (TCM) for COVID-19 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Taditional Chinese Medicine (TCM) for COVID-19 market include China Beijing Tong Ren Tang Group Co., Ltd., Yiling Pharmaceutical, Southwest Pharmaceutical, Beijing Juxiechang Pharmaceutical, Jiuzhitang, Jiangsu Jichuan Holding Group Co., Ltd., Tianjin Chase Sun Pharmaceutical, Guizhou Yibai Pharmaceutical and Sunflower, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Taditional Chinese Medicine (TCM) for COVID-19 market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Taditional Chinese Medicine (TCM) for COVID-19 market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Taditional Chinese Medicine (TCM) for COVID-19 market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Taditional Chinese Medicine (TCM) for COVID-19.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Taditional Chinese Medicine (TCM) for COVID-19 market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Taditional Chinese Medicine (TCM) for COVID-19 Market by Company

China Beijing Tong Ren Tang Group Co., Ltd.

Yiling Pharmaceutical

Southwest Pharmaceutical

Beijing Juxiechang Pharmaceutical

Jiuzhitang

Jiangsu Jichuan Holding Group Co., Ltd.

Tianjin Chase Sun Pharmaceutical

Guizhou Yibai Pharmaceutical

Sunflower

Qingfeng Pharmaceutical Group

Jiren Pharmaceutical Group

Taditional Chinese Medicine (TCM) for COVID-19 Segment by Type

Jinhua Qinggan Granules

Lianhua Qingwen Capsule

Xuebijing Injection

TCM Prescription

Other

Taditional Chinese Medicine (TCM) for COVID-19 Segment by Application

Hospital

Clinic

Other

Taditional Chinese Medicine (TCM) for COVID-19 Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Taditional Chinese Medicine (TCM) for COVID-19 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Taditional Chinese Medicine (TCM) for COVID-19 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Taditional Chinese Medicine (TCM) for COVID-19.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Taditional Chinese Medicine (TCM) for COVID-19 companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Taditional Chinese Medicine (TCM) for COVID-19 Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Taditional Chinese Medicine (TCM) for COVID-19 Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Taditional Chinese Medicine (TCM) for COVID-19 Market Share by Region (2021-2026) Table 4. Global Taditional Chinese Medicine (TCM) for COVID-19 Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Taditional Chinese Medicine (TCM) for COVID-19 Market Share by Region (2027-2032) Table 6. Global Taditional Chinese Medicine (TCM) for COVID-19 Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Taditional Chinese Medicine (TCM) for COVID-19 Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Taditional Chinese Medicine (TCM) for COVID-19 Market Size Share by Type (2021-2026) Table 9. Global Taditional Chinese Medicine (TCM) for COVID-19 Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Taditional Chinese Medicine (TCM) for COVID-19 Market Size Share Forecasted by Type (2027-2032) Table 11. North America Taditional Chinese Medicine (TCM) for COVID-19 Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Taditional Chinese Medicine (TCM) for COVID-19 Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Taditional Chinese Medicine (TCM) for COVID-19 Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Taditional Chinese Medicine (TCM) for COVID-19 Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Taditional Chinese Medicine (TCM) for COVID-19 Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Taditional Chinese Medicine (TCM) for COVID-19 Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Taditional Chinese Medicine (TCM) for COVID-19 Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Taditional Chinese Medicine (TCM) for COVID-19 Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Taditional Chinese Medicine (TCM) for COVID-19 Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Taditional Chinese Medicine (TCM) for COVID-19 Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Taditional Chinese Medicine (TCM) for COVID-19 Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Taditional Chinese Medicine (TCM) for COVID-19 Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Taditional Chinese Medicine (TCM) for COVID-19 Market Size Share by Application (2021-2026) Table 24. Global Taditional Chinese Medicine (TCM) for COVID-19 Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Taditional Chinese Medicine (TCM) for COVID-19 Market Size Share Forecasted by Application (2027-2032) Table 26. North America Taditional Chinese Medicine (TCM) for COVID-19 Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Taditional Chinese Medicine (TCM) for COVID-19 Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Taditional Chinese Medicine (TCM) for COVID-19 Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Taditional Chinese Medicine (TCM) for COVID-19 Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Taditional Chinese Medicine (TCM) for COVID-19 Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Taditional Chinese Medicine (TCM) for COVID-19 Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Taditional Chinese Medicine (TCM) for COVID-19 Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Taditional Chinese Medicine (TCM) for COVID-19 Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Taditional Chinese Medicine (TCM) for COVID-19 Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Taditional Chinese Medicine (TCM) for COVID-19 Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Taditional Chinese Medicine (TCM) for COVID-19 Industry Trends Table 37. Taditional Chinese Medicine (TCM) for COVID-19 Industry Drivers Table 38. Taditional Chinese Medicine (TCM) for COVID-19 Industry Opportunities and Challenges Table 39. Taditional Chinese Medicine (TCM) for COVID-19 Industry Restraints Table 40. Global Taditional Chinese Medicine (TCM) for COVID-19 Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Taditional Chinese Medicine (TCM) for COVID-19 Revenue Market Share by Company (2021-2026) Table 42. Global Taditional Chinese Medicine (TCM) for COVID-19 Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Taditional Chinese Medicine (TCM) for COVID-19 Key Company Headquarters & Area Served Table 44. Global Taditional Chinese Medicine (TCM) for COVID-19 Company, Product Type & Application Table 45. Global Taditional Chinese Medicine (TCM) for COVID-19 Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Taditional Chinese Medicine (TCM) for COVID-19 by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. China Beijing Tong Ren Tang Group Co., Ltd. Company Information Table 49. China Beijing Tong Ren Tang Group Co., Ltd. Business Overview Table 50. China Beijing Tong Ren Tang Group Co., Ltd. Taditional Chinese Medicine (TCM) for COVID-19 Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. China Beijing Tong Ren Tang Group Co., Ltd. Taditional Chinese Medicine (TCM) for COVID-19 Product Portfolio Table 52. China Beijing Tong Ren Tang Group Co., Ltd. Recent Development Table 53. Yiling Pharmaceutical Company Information Table 54. Yiling Pharmaceutical Business Overview Table 55. Yiling Pharmaceutical Taditional Chinese Medicine (TCM) for COVID-19 Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Yiling Pharmaceutical Taditional Chinese Medicine (TCM) for COVID-19 Product Portfolio Table 57. Yiling Pharmaceutical Recent Development Table 58. Southwest Pharmaceutical Company Information Table 59. Southwest Pharmaceutical Business Overview Table 60. Southwest Pharmaceutical Taditional Chinese Medicine (TCM) for COVID-19 Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Southwest Pharmaceutical Taditional Chinese Medicine (TCM) for COVID-19 Product Portfolio Table 62. Southwest Pharmaceutical Recent Development Table 63. Beijing Juxiechang Pharmaceutical Company Information Table 64. Beijing Juxiechang Pharmaceutical Business Overview Table 65. Beijing Juxiechang Pharmaceutical Taditional Chinese Medicine (TCM) for COVID-19 Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Beijing Juxiechang Pharmaceutical Taditional Chinese Medicine (TCM) for COVID-19 Product Portfolio Table 67. Beijing Juxiechang Pharmaceutical Recent Development Table 68. Jiuzhitang Company Information Table 69. Jiuzhitang Business Overview Table 70. Jiuzhitang Taditional Chinese Medicine (TCM) for COVID-19 Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Jiuzhitang Taditional Chinese Medicine (TCM) for COVID-19 Product Portfolio Table 72. Jiuzhitang Recent Development Table 73. Jiangsu Jichuan Holding Group Co., Ltd. Company Information Table 74. Jiangsu Jichuan Holding Group Co., Ltd. Business Overview Table 75. Jiangsu Jichuan Holding Group Co., Ltd. Taditional Chinese Medicine (TCM) for COVID-19 Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Jiangsu Jichuan Holding Group Co., Ltd. Taditional Chinese Medicine (TCM) for COVID-19 Product Portfolio Table 77. Jiangsu Jichuan Holding Group Co., Ltd. Recent Development Table 78. Tianjin Chase Sun Pharmaceutical Company Information Table 79. Tianjin Chase Sun Pharmaceutical Business Overview Table 80. Tianjin Chase Sun Pharmaceutical Taditional Chinese Medicine (TCM) for COVID-19 Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Tianjin Chase Sun Pharmaceutical Taditional Chinese Medicine (TCM) for COVID-19 Product Portfolio Table 82. Tianjin Chase Sun Pharmaceutical Recent Development Table 83. Guizhou Yibai Pharmaceutical Company Information Table 84. Guizhou Yibai Pharmaceutical Business Overview Table 85. Guizhou Yibai Pharmaceutical Taditional Chinese Medicine (TCM) for COVID-19 Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Guizhou Yibai Pharmaceutical Taditional Chinese Medicine (TCM) for COVID-19 Product Portfolio Table 87. Guizhou Yibai Pharmaceutical Recent Development Table 88. Sunflower Company Information Table 89. Sunflower Business Overview Table 90. Sunflower Taditional Chinese Medicine (TCM) for COVID-19 Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Sunflower Taditional Chinese Medicine (TCM) for COVID-19 Product Portfolio Table 92. Sunflower Recent Development Table 93. Qingfeng Pharmaceutical Group Company Information Table 94. Qingfeng Pharmaceutical Group Business Overview Table 95. Qingfeng Pharmaceutical Group Taditional Chinese Medicine (TCM) for COVID-19 Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Qingfeng Pharmaceutical Group Taditional Chinese Medicine (TCM) for COVID-19 Product Portfolio Table 97. Qingfeng Pharmaceutical Group Recent Development Table 98. Jiren Pharmaceutical Group Company Information Table 99. Jiren Pharmaceutical Group Business Overview Table 100. Jiren Pharmaceutical Group Taditional Chinese Medicine (TCM) for COVID-19 Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Jiren Pharmaceutical Group Taditional Chinese Medicine (TCM) for COVID-19 Product Portfolio Table 102. Jiren Pharmaceutical Group Recent Development Table 103. North America Taditional Chinese Medicine (TCM) for COVID-19 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 104. North America Taditional Chinese Medicine (TCM) for COVID-19 Market Size by Country (2021-2026) & (US$ Million) Table 105. North America Taditional Chinese Medicine (TCM) for COVID-19 Market Share by Country (2021-2026) Table 106. North America Taditional Chinese Medicine (TCM) for COVID-19 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 107. North America Taditional Chinese Medicine (TCM) for COVID-19 Market Share Forecast by Country (2027-2032) Table 108. Europe Taditional Chinese Medicine (TCM) for COVID-19 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 109. Europe Taditional Chinese Medicine (TCM) for COVID-19 Market Size by Country (2021-2026) & (US$ Million) Table 110. Europe Taditional Chinese Medicine (TCM) for COVID-19 Market Share by Country (2021-2026) Table 111. Europe Taditional Chinese Medicine (TCM) for COVID-19 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 112. Europe Taditional Chinese Medicine (TCM) for COVID-19 Market Share Forecast by Country (2027-2032) Table 113. Asia-Pacific Taditional Chinese Medicine (TCM) for COVID-19 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 114. Asia-Pacific Taditional Chinese Medicine (TCM) for COVID-19 Market Size by Country (2021-2026) & (US$ Million) Table 115. Asia-Pacific Taditional Chinese Medicine (TCM) for COVID-19 Market Share by Country (2021-2026) Table 116. Asia-Pacific Taditional Chinese Medicine (TCM) for COVID-19 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 117. Asia-Pacific Taditional Chinese Medicine (TCM) for COVID-19 Market Share Forecast by Country (2027-2032) Table 118. Latin America Taditional Chinese Medicine (TCM) for COVID-19 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. Latin America Taditional Chinese Medicine (TCM) for COVID-19 Market Size by Country (2021-2026) & (US$ Million) Table 120. Latin America Taditional Chinese Medicine (TCM) for COVID-19 Market Share by Country (2021-2026) Table 121. Latin America Taditional Chinese Medicine (TCM) for COVID-19 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. Latin America Taditional Chinese Medicine (TCM) for COVID-19 Market Share Forecast by Country (2027-2032) Table 123. Middle East & Africa Taditional Chinese Medicine (TCM) for COVID-19 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. Middle East & Africa Taditional Chinese Medicine (TCM) for COVID-19 Market Size by Country (2021-2026) & (US$ Million) Table 125. Middle East & Africa Taditional Chinese Medicine (TCM) for COVID-19 Market Share by Country (2021-2026) Table 126. Middle East & Africa Taditional Chinese Medicine (TCM) for COVID-19 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. Middle East & Africa Taditional Chinese Medicine (TCM) for COVID-19 Market Share Forecast by Country (2027-2032) Table 128. Research Programs/Design for This Report Table 129. Authors List of This Report Table 130. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Taditional Chinese Medicine (TCM) for COVID-19 Product Image Figure 3. Global Taditional Chinese Medicine (TCM) for COVID-19 Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Taditional Chinese Medicine (TCM) for COVID-19 Market Size (2021-2032) & (US$ Million) Figure 5. Global Taditional Chinese Medicine (TCM) for COVID-19 Market Share by Region: 2025 VS 2032 Figure 6. Global Taditional Chinese Medicine (TCM) for COVID-19 Market Share by Region (2021-2032) Figure 7. North America Taditional Chinese Medicine (TCM) for COVID-19 Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Taditional Chinese Medicine (TCM) for COVID-19 Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Taditional Chinese Medicine (TCM) for COVID-19 Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Taditional Chinese Medicine (TCM) for COVID-19 Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Taditional Chinese Medicine (TCM) for COVID-19 Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Jinhua Qinggan Granules Image Figure 13. Global Jinhua Qinggan Granules Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Lianhua Qingwen Capsule Image Figure 15. Global Lianhua Qingwen Capsule Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Xuebijing Injection Image Figure 17. Global Xuebijing Injection Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. TCM Prescription Image Figure 19. Global TCM Prescription Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Other Image Figure 21. Global Other Market Size YoY Growth (2021-2032) & (US$ Million) Figure 22. Global Taditional Chinese Medicine (TCM) for COVID-19 Market Size Overview by Type (2021-2032) & (US$ Million) Figure 23. Global Taditional Chinese Medicine (TCM) for COVID-19 Market Share by Type 2025 VS 2032 Figure 24. North America Taditional Chinese Medicine (TCM) for COVID-19 Market Size Share by Type (2021-2032) Figure 25. Europe Taditional Chinese Medicine (TCM) for COVID-19 Market Size Share by Type (2021-2032) Figure 26. Asia-Pacific Taditional Chinese Medicine (TCM) for COVID-19 Market Size Share by Type (2021-2032) Figure 27. Latin America Taditional Chinese Medicine (TCM) for COVID-19 Market Size Share by Type (2021-2032) Figure 28. Middle East and Africa Taditional Chinese Medicine (TCM) for COVID-19 Market Size Share by Type (2021-2032) Figure 29. Hospital Image Figure 30. Global Hospital Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Clinic Image Figure 32. Global Clinic Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Other Image Figure 34. Global Other Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Global Taditional Chinese Medicine (TCM) for COVID-19 Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Taditional Chinese Medicine (TCM) for COVID-19 Market Share by Application 2025 VS 2032 Figure 37. North America Taditional Chinese Medicine (TCM) for COVID-19 Market Size Share by Application (2021-2032) Figure 38. Europe Taditional Chinese Medicine (TCM) for COVID-19 Market Size Share by Application (2021-2032) Figure 39. Asia-Pacific Taditional Chinese Medicine (TCM) for COVID-19 Market Size Share by Application (2021-2032) Figure 40. Latin America Taditional Chinese Medicine (TCM) for COVID-19 Market Size Share by Application (2021-2032) Figure 41. Middle East and Africa Taditional Chinese Medicine (TCM) for COVID-19 Market Size Share by Application (2021-2032) Figure 42. Global Top 5 and 10 Taditional Chinese Medicine (TCM) for COVID-19 Players Market Share by Revenue in 2025 Figure 43. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 44. North America Taditional Chinese Medicine (TCM) for COVID-19 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 45. North America Taditional Chinese Medicine (TCM) for COVID-19 Market Share by Country: 2021 VS 2025 VS 2032 Figure 46. North America Taditional Chinese Medicine (TCM) for COVID-19 Market Share by Country (2021-2032) Figure 47. Europe Taditional Chinese Medicine (TCM) for COVID-19 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Taditional Chinese Medicine (TCM) for COVID-19 Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Taditional Chinese Medicine (TCM) for COVID-19 Market Share by Country (2021-2032) Figure 50. Asia-Pacific Taditional Chinese Medicine (TCM) for COVID-19 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. Asia-Pacific Taditional Chinese Medicine (TCM) for COVID-19 Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. Asia-Pacific Taditional Chinese Medicine (TCM) for COVID-19 Market Share by Country (2021-2032) Figure 53. Latin America Taditional Chinese Medicine (TCM) for COVID-19 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Taditional Chinese Medicine (TCM) for COVID-19 Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Taditional Chinese Medicine (TCM) for COVID-19 Market Share by Country (2021-2032) Figure 56. Middle East & Africa Taditional Chinese Medicine (TCM) for COVID-19 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Middle East & Africa Taditional Chinese Medicine (TCM) for COVID-19 Market Share by Country: 2021 VS 2025 VS 2032 Figure 58. Middle East & Africa Taditional Chinese Medicine (TCM) for COVID-19 Market Share by Country (2021-2032) Figure 59. Years Considered Figure 60. Research Process Figure 61. Key Executives Interviewed

Scope & coverage.

Types
  • Jinhua Qinggan Granules
  • Lianhua Qingwen Capsule
  • Xuebijing Injection
  • TCM Prescription
  • Other
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • China Beijing Tong Ren Tang Group Co., Ltd.
  • Yiling Pharmaceutical
  • Southwest Pharmaceutical
  • Beijing Juxiechang Pharmaceutical
  • Jiuzhitang
  • Jiangsu Jichuan Holding Group Co., Ltd.
  • Tianjin Chase Sun Pharmaceutical
  • Guizhou Yibai Pharmaceutical
  • Sunflower
  • Qingfeng Pharmaceutical Group
  • Jiren Pharmaceutical Group

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Taditional Chinese Medicine (TCM) for COVID-19 Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Taditional Chinese Medicine (TCM) for COVID-19 Market Size by Region (2021-2032)
  5. 1.4.1 Global Taditional Chinese Medicine (TCM) for COVID-19 Market Size by Region (2021-2026)
  6. 1.4.2 Global Taditional Chinese Medicine (TCM) for COVID-19 Market Size by Region (2027-2032)
  7. 1.5 Key Regions Taditional Chinese Medicine (TCM) for COVID-19 Market Size (2021-2032)
  8. 1.5.1 North America Taditional Chinese Medicine (TCM) for COVID-19 Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Taditional Chinese Medicine (TCM) for COVID-19 Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Taditional Chinese Medicine (TCM) for COVID-19 Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Taditional Chinese Medicine (TCM) for COVID-19 Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Taditional Chinese Medicine (TCM) for COVID-19 Market Size Growth Rate (2021-2032)
2 Taditional Chinese Medicine (TCM) for COVID-19 Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Jinhua Qinggan Granules
  3. 2.1.2 Lianhua Qingwen Capsule
  4. 2.1.3 Xuebijing Injection
  5. 2.1.4 TCM Prescription
  6. 2.1.5 Other
  7. 2.2 Global Taditional Chinese Medicine (TCM) for COVID-19 Market Size by Type
  8. 2.2.1 Global Taditional Chinese Medicine (TCM) for COVID-19 Market Size Overview by Type (2021-2032)
  9. 2.2.2 Global Taditional Chinese Medicine (TCM) for COVID-19 Historic Market Size Review by Type (2021-2026)
  10. 2.2.3 Global Taditional Chinese Medicine (TCM) for COVID-19 Market Size Forecasted by Type (2027-2032)
  11. 2.3 Global Taditional Chinese Medicine (TCM) for COVID-19 Market Size by Regions
  12. 2.3.1 North America Taditional Chinese Medicine (TCM) for COVID-19 Market Size Breakdown by Type (2021-2026)
  13. 2.3.2 Europe Taditional Chinese Medicine (TCM) for COVID-19 Market Size Breakdown by Type (2021-2026)
  14. 2.3.3 Asia-Pacific Taditional Chinese Medicine (TCM) for COVID-19 Market Size Breakdown by Type (2021-2026)
  15. 2.3.4 South America Taditional Chinese Medicine (TCM) for COVID-19 Market Size Breakdown by Type (2021-2026)
  16. 2.3.5 Middle East and Africa Taditional Chinese Medicine (TCM) for COVID-19 Market Size Breakdown by Type (2021-2026)
3 Taditional Chinese Medicine (TCM) for COVID-19 Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Hospital
  3. 3.1.2 Clinic
  4. 3.1.3 Other
  5. 3.2 Global Taditional Chinese Medicine (TCM) for COVID-19 Market Size by Application
  6. 3.2.1 Global Taditional Chinese Medicine (TCM) for COVID-19 Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global Taditional Chinese Medicine (TCM) for COVID-19 Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global Taditional Chinese Medicine (TCM) for COVID-19 Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global Taditional Chinese Medicine (TCM) for COVID-19 Market Size by Regions
  10. 3.3.1 North America Taditional Chinese Medicine (TCM) for COVID-19 Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe Taditional Chinese Medicine (TCM) for COVID-19 Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific Taditional Chinese Medicine (TCM) for COVID-19 Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America Taditional Chinese Medicine (TCM) for COVID-19 Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa Taditional Chinese Medicine (TCM) for COVID-19 Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Taditional Chinese Medicine (TCM) for COVID-19 Industry Trends
  2. 4.2 Taditional Chinese Medicine (TCM) for COVID-19 Industry Drivers
  3. 4.3 Taditional Chinese Medicine (TCM) for COVID-19 Industry Opportunities and Challenges
  4. 4.4 Taditional Chinese Medicine (TCM) for COVID-19 Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Taditional Chinese Medicine (TCM) for COVID-19 Revenue (2021-2026)
  2. 5.2 Global Taditional Chinese Medicine (TCM) for COVID-19 Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Taditional Chinese Medicine (TCM) for COVID-19 Key Company Headquarters & Area Served
  4. 5.4 Global Taditional Chinese Medicine (TCM) for COVID-19 Company, Product Type & Application
  5. 5.5 Global Taditional Chinese Medicine (TCM) for COVID-19 Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Taditional Chinese Medicine (TCM) for COVID-19 Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Taditional Chinese Medicine (TCM) for COVID-19 Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Taditional Chinese Medicine (TCM) for COVID-19 Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 China Beijing Tong Ren Tang Group Co., Ltd.
  2. 6.1.1 China Beijing Tong Ren Tang Group Co., Ltd. Company Information
  3. 6.1.2 China Beijing Tong Ren Tang Group Co., Ltd. Business Overview
  4. 6.1.3 China Beijing Tong Ren Tang Group Co., Ltd. Taditional Chinese Medicine (TCM) for COVID-19 Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 China Beijing Tong Ren Tang Group Co., Ltd. Taditional Chinese Medicine (TCM) for COVID-19 Product Portfolio
  6. 6.1.5 China Beijing Tong Ren Tang Group Co., Ltd. Recent Developments
  7. 6.2 Yiling Pharmaceutical
  8. 6.2.1 Yiling Pharmaceutical Company Information
  9. 6.2.2 Yiling Pharmaceutical Business Overview
  10. 6.2.3 Yiling Pharmaceutical Taditional Chinese Medicine (TCM) for COVID-19 Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Yiling Pharmaceutical Taditional Chinese Medicine (TCM) for COVID-19 Product Portfolio
  12. 6.2.5 Yiling Pharmaceutical Recent Developments
  13. 6.3 Southwest Pharmaceutical
  14. 6.3.1 Southwest Pharmaceutical Company Information
  15. 6.3.2 Southwest Pharmaceutical Business Overview
  16. 6.3.3 Southwest Pharmaceutical Taditional Chinese Medicine (TCM) for COVID-19 Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Southwest Pharmaceutical Taditional Chinese Medicine (TCM) for COVID-19 Product Portfolio
  18. 6.3.5 Southwest Pharmaceutical Recent Developments
  19. 6.4 Beijing Juxiechang Pharmaceutical
  20. 6.4.1 Beijing Juxiechang Pharmaceutical Company Information
  21. 6.4.2 Beijing Juxiechang Pharmaceutical Business Overview
  22. 6.4.3 Beijing Juxiechang Pharmaceutical Taditional Chinese Medicine (TCM) for COVID-19 Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Beijing Juxiechang Pharmaceutical Taditional Chinese Medicine (TCM) for COVID-19 Product Portfolio
  24. 6.4.5 Beijing Juxiechang Pharmaceutical Recent Developments
  25. 6.5 Jiuzhitang
  26. 6.5.1 Jiuzhitang Company Information
  27. 6.5.2 Jiuzhitang Business Overview
  28. 6.5.3 Jiuzhitang Taditional Chinese Medicine (TCM) for COVID-19 Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Jiuzhitang Taditional Chinese Medicine (TCM) for COVID-19 Product Portfolio
  30. 6.5.5 Jiuzhitang Recent Developments
  31. 6.6 Jiangsu Jichuan Holding Group Co., Ltd.
  32. 6.6.1 Jiangsu Jichuan Holding Group Co., Ltd. Company Information
  33. 6.6.2 Jiangsu Jichuan Holding Group Co., Ltd. Business Overview
  34. 6.6.3 Jiangsu Jichuan Holding Group Co., Ltd. Taditional Chinese Medicine (TCM) for COVID-19 Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Jiangsu Jichuan Holding Group Co., Ltd. Taditional Chinese Medicine (TCM) for COVID-19 Product Portfolio
  36. 6.6.5 Jiangsu Jichuan Holding Group Co., Ltd. Recent Developments
  37. 6.7 Tianjin Chase Sun Pharmaceutical
  38. 6.7.1 Tianjin Chase Sun Pharmaceutical Company Information
  39. 6.7.2 Tianjin Chase Sun Pharmaceutical Business Overview
  40. 6.7.3 Tianjin Chase Sun Pharmaceutical Taditional Chinese Medicine (TCM) for COVID-19 Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Tianjin Chase Sun Pharmaceutical Taditional Chinese Medicine (TCM) for COVID-19 Product Portfolio
  42. 6.7.5 Tianjin Chase Sun Pharmaceutical Recent Developments
  43. 6.8 Guizhou Yibai Pharmaceutical
  44. 6.8.1 Guizhou Yibai Pharmaceutical Company Information
  45. 6.8.2 Guizhou Yibai Pharmaceutical Business Overview
  46. 6.8.3 Guizhou Yibai Pharmaceutical Taditional Chinese Medicine (TCM) for COVID-19 Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Guizhou Yibai Pharmaceutical Taditional Chinese Medicine (TCM) for COVID-19 Product Portfolio
  48. 6.8.5 Guizhou Yibai Pharmaceutical Recent Developments
  49. 6.9 Sunflower
  50. 6.9.1 Sunflower Company Information
  51. 6.9.2 Sunflower Business Overview
  52. 6.9.3 Sunflower Taditional Chinese Medicine (TCM) for COVID-19 Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Sunflower Taditional Chinese Medicine (TCM) for COVID-19 Product Portfolio
  54. 6.9.5 Sunflower Recent Developments
  55. 6.10 Qingfeng Pharmaceutical Group
  56. 6.10.1 Qingfeng Pharmaceutical Group Company Information
  57. 6.10.2 Qingfeng Pharmaceutical Group Business Overview
  58. 6.10.3 Qingfeng Pharmaceutical Group Taditional Chinese Medicine (TCM) for COVID-19 Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Qingfeng Pharmaceutical Group Taditional Chinese Medicine (TCM) for COVID-19 Product Portfolio
  60. 6.10.5 Qingfeng Pharmaceutical Group Recent Developments
  61. 6.11 Jiren Pharmaceutical Group
  62. 6.11.1 Jiren Pharmaceutical Group Company Information
  63. 6.11.2 Jiren Pharmaceutical Group Business Overview
  64. 6.11.3 Jiren Pharmaceutical Group Taditional Chinese Medicine (TCM) for COVID-19 Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Jiren Pharmaceutical Group Taditional Chinese Medicine (TCM) for COVID-19 Product Portfolio
  66. 6.11.5 Jiren Pharmaceutical Group Recent Developments
7 North America
  1. 7.1 North America Taditional Chinese Medicine (TCM) for COVID-19 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Taditional Chinese Medicine (TCM) for COVID-19 Market Size by Country (2021-2026)
  3. 7.3 North America Taditional Chinese Medicine (TCM) for COVID-19 Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Taditional Chinese Medicine (TCM) for COVID-19 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Taditional Chinese Medicine (TCM) for COVID-19 Market Size by Country (2021-2026)
  3. 8.3 Europe Taditional Chinese Medicine (TCM) for COVID-19 Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Taditional Chinese Medicine (TCM) for COVID-19 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Taditional Chinese Medicine (TCM) for COVID-19 Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Taditional Chinese Medicine (TCM) for COVID-19 Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Taditional Chinese Medicine (TCM) for COVID-19 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Taditional Chinese Medicine (TCM) for COVID-19 Market Size by Country (2021-2026)
  3. 10.3 South America Taditional Chinese Medicine (TCM) for COVID-19 Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Taditional Chinese Medicine (TCM) for COVID-19 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Taditional Chinese Medicine (TCM) for COVID-19 Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Taditional Chinese Medicine (TCM) for COVID-19 Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst